Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 9130567

Thiols decrease human IL-4 production and IL-4-induced immunoglobulin synthesis.

P Jeannin·Y Delneste·J P Aubry·S Lecoanet-Henchoz·J F Gauchat·P Life·J Y Bonnefoy
View original source ↗Export metadata ↓

Abstract

The source did not provide an abstract. Follow the original record for more information.

Explore related subjects

AcetylcysteineCD40 AntigensGlutathioneHumansImmunoglobulinsInterleukin-4Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

P Jeannin, Y Delneste, J P Aubry, S Lecoanet-Henchoz, J F Gauchat, P Life, J Y Bonnefoy. Thiols decrease human IL-4 production and IL-4-induced immunoglobulin synthesis.. https://doi.org/10.1159/000237591

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1999

Proteasome inhibitors MG132 and lactacystin hyperphosphorylate HSF1 and induce hsp70 and hsp27 expression.

MG132 and lactacystin, two 26S proteasome-specific protease inhibitors, can upregulate heat-shock gene transcription without heat shock. In this study, we showed that both of these inhibitors induce hyperphosphorylation and DNA-binding activity of HSF1 in the absence of heat shock (at 37 degreesC). Since trimerization of HSF1 is known to precede the acquisition of HSF1-DNA binding activity, it seems that MG132- and lactacystin-induced hyperphosphorylation of HSF1 causes conformational changes of HSF1 molecules at 37 degreesC and subsequently triggers its trimerization. Inhibition of protein synthesis by cycloheximide abolished the MG132- or lactacystin-induced hyperphosphorylation and DNA-binding activity of HSF1. These data suggest that the activity of a putative kinase(s) targeting HSF1 is upregulated in the presence of MG132 or lactacystin. The upregulation of the kinase activity requires de novo protein synthesis and is likely due to the inhibition of protein degradation of a short-lived, kinase(s) targeting HSF1 and/or the cofactor(s) for the kinases, through the ubiquitin-proteasome pathway.

Acetylcysteine↗
PubMed1999

Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system.

Arsenic trioxide (As2O3) induces clinical remission in acute promyelocytic leukemia (APL) with minimal toxicity and apoptosis in APL-derived NB4 cells at low (1 to 2 micromol/L) concentration. We examined the basis for NB4 cell sensitivity to As2O3 to identify experimental conditions that would render other malignant cells responsive to low concentrations of As2O3. The intracellular glutathione (GSH) content had a decisive effect on As2O3-induced apoptosis. Highly sensitive NB4 cells had the lowest GSH and the sensitivity of other cell lines was inversely proportional to their GSH content. The t(14;18) B-cell lymphoma cell line had low GSH levels and sensitivity to As2O3 at levels slightly higher than in APL cells. Experimental upmodulation of GSH content decreased the sensitivity to As2O3. Ascorbic acid and buthionine sulfoxide (BSO) decreased GSH to a greater extent, and rendered malignant cells more sensitive to As2O3. As2O3-induced apoptosis was not enhanced by ascorbic acid in normal cells, suggesting that the combination of ascorbic acid and As2O3 may be selectively toxic to some malignant cells. Ascorbic acid enhanced the antilymphoma effect of As2O3 in vivo without additional toxicity. Thus, As2O3 alone or administered with ascorbic acid may provide a novel therapy for lymphoma.

Acetylcysteine↗